AmeriCann CEO to Present at Massachusetts State House News Forum

ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse style cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at State House News Forum “Massachusetts’ Expanding Cannabis Economy” held in Boston, MA, on Wednesday, June 26, starting at 8am ET.” data-reactid=”11″>DENVER, CO / ACCESSWIRE / June 19, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse style cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at State House News Forum “Massachusetts’ Expanding Cannabis Economy” held in Boston, MA, on Wednesday, June 26, starting at 8am ET.

The Forum will kickoff with an address by Massachusetts’ Cannabis Control Commission’s Executive Director Shawn Collins and two lively panel discussions with experts from government, law, and the state’s rapidly evolving marijuana industry about the many challenges and opportunities in Massachusetts. Mr. Keogh will be speaking about the expanding cannabis industry’s statewide potential, including investment, job growth, tax revenue, real estate and tourism.

Tim Keogh, AmeriCann CEO, has spoken at cannabis industry conferences across the United States as an expert on topics including industry best practices, real estate development and the cannabis economy. In January of 2018, Marijuana Business Daily recognized Mr. Keogh as one of the “Top People to Watch in 2018.”

AmeriCann is developing the Massachusetts Medical Cannabis Center (MMCC), a state-of-the-art cannabis cultivation and processing development in the midst of the rapidly growing Massachusetts medical cannabis market. The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation.

“Massachusetts is one of the most dynamic developing cannabis markets in the United States,” stated AmeriCann CEO Tim Keogh. “Our MMCC project is positioned to become a center of excellence for quality, consistency, and efficiency and play an important role in helping to provide the cannabis infrastructure the Commonwealth requires.”

In 2016, AmeriCann formed an alliance with BASK, Inc. (formerly known as Coastal Compassion, Inc.) as a Preferred Partner in Massachusetts. BASK is scheduled to be the first cultivation and processing business in AmeriCann’s Massachusetts Medical Cannabis Center. This alliance makes AmeriCann one of the only publicly traded companies that have a partnership with an operating dispensary in the Massachusetts market.

1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. Voters in Massachusetts approved legalizing the adult use of recreational marijuana in November of 2016. The state is on track to open the first cannabis storefronts for Adult-Use by July 1, 2018, making Massachusetts the first state in the Northeast to legalize adult-use cannabis.” data-reactid=”22″>AmeriCann’s flagship project, The Massachusetts Medical Cannabis Center, is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. Voters in Massachusetts approved legalizing the adult use of recreational marijuana in November of 2016. The state is on track to open the first cannabis storefronts for Adult-Use by July 1, 2018, making Massachusetts the first state in the Northeast to legalize adult-use cannabis.

AmeriCann’s Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures. The company is planning to replicate the Cannopy platform in additional states.

The first phase of the MMCC project consists of 30,000 sq. ft. of cultivation, processing and research facility.

www.cometobask.com or its social media links below:” data-reactid=”37″>Bask, Inc. (“BASK” or “BASK Premium Cannabis”) is one of a limited number of vertically integrated medical marijuana companies that are operating in the Massachusetts market. BASK Premium Cannabis has received all necessary approvals to grow, process and dispense medical marijuana to registered patients in the Massachusetts Medical-Use of Marijuana Program. In addition, BASK has received Priority Certification by the Cannabis Control Commission which allows for expedited application processing for Adult-Use Cannabis which is scheduled to start July 1, 2018. BASK is scheduled to be the first business to operate in AmeriCann’s Massachusetts Medical Cannabis Center. For more information on BASK, visit www.cometobask.com or its social media links below:

www.sec.gov.” data-reactid=”40″>This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,””anticipate,””estimate,””expect,””intend,””plan,””project,””prospects,””outlook,” and similar words or expressions, or future or conditional verbs such as “will,””should,””would,””may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Registration Statement on Form S-1, which the Company recently filed with the SEC and which may be viewed at www.sec.gov.

Hayden IR
hart@haydenir.com
(917) 658-7878′ data-reactid=”43″>Investors:
Hayden IR
hart@haydenir.com
(917) 658-7878

Source

The post AmeriCann CEO to Present at Massachusetts State House News Forum appeared first on Cannabis Stock Picks.

Go to OG News Source
Author: Admin